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Abstract
Our objective was to assess the presence of three polyomaviruses, namely SV40, JCPyV, and BKPyV, and human papilloma-
viruses (HPV) in adenoid cystic carcinomas (ACC) of the minor salivary glands (MiSG) in the head and neck region. The study
comprised 68 MiSG ACC patients operated during 1974–2012 at the Helsinki University Hospital (Helsinki, Finland). Medical
records and 68 histological samples were reviewed. Polyomaviruses were detected with quantitative PCR and the DNA-positive
samples were further analyzed for the presence of viral tumor Tantigen (T-ag) with immunohistochemistry. HPV genotyping was
performed with a Multiplex HPVGenotyping Kit. Only JCPyVDNAwas found in ACC samples, being present in 7 (10.3%) out
of the 68 samples. The viral load of JCPyV was low varying between 1 to 226 copies/μg DNA. The JCPyV-positive samples
originated from trachea (two samples), paranasal sinuses (one), and oral cavity (two). Additionally, JCPyV positivity was found
in one lung metastasis of a tracheal tumor and one local disease failure of an oral cavity tumor. Three JCPyV DNA-positive
samples showed weak nuclear staining for large T-ag. In conclusion, only JCPyV but not SV40, BKPyV, or HPV was found in
ACC from the upper and lower airways. JCPyV copy numbers were low which might support its role as a “hit and run agent” in
ACC carcinogenesis.
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Introduction
Adenoid cystic carcinoma (ACC) is a rare malignancy of glan-
dular structures, which most commonly (70%) appears in sal-
ivary glands [1]. Minor glands (MiSGs) are involved more
often than major glands (MaSGs) [1, 2]. Etiopathogenesis for
ACC as well as for many other salivary gland tumors is still
unknown. In ACC, genetic studies have found MYB/NFIB
translocations and this fusion oncogene is overexpressed [3].
In addition, studies have provided evidence for Notch-pathway
alterations in 11 to 29% of patients [4]. As the pathogenesis of
ACC remains unknown, even viral background should be con-
sidered. Distinguished viral etiological factors among head and
neck cancers are Epstein-Barr virus (EBV) in nasopharyngeal
carcinoma and human papilloma virus (HPV) 16 in oropha-
ryngeal squamous cell carcinoma [5, 6].
Furthermore, head and neck cancer studies have gained
new knowledge on polyomaviruses (HPyVs) and their coin-
fection with other viruses [7–11]. A recent study on oncogenic
DNAviruses in salivary gland tumors increases the interest on
possible role of HPyVs in the pathogenesis of salivary gland
tumors [12].
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Currently, 13 human HPyVs have been identified [13, 14].
Among them, Merkel cell polyomavirus (MCPyV), BK poly-
omavirus (BKPyV), and JC polyomavirus (JCPyV) have been
associated with human cancers [13]. MCPyV is classified as a
grade 2A carcinogen (probable carcinogen) by IARC while
BKPyVand JCPyVare grade 2B carcinogens (possibly carci-
nogenic to humans) [13]. Simian vacuolating virus 40 (SV40)
has an ability to cause cancer in animal models but clinical
consequences to humans are controversial although SV40 con-
taminated polio vaccine was used during the years 1955–1963
[13, 15, 16]. HPyVs are small non-enveloped viruses
consisting of circular double-stranded DNA genome (5.2 kb)
that has two transcriptional units, early and late region [13].
The former encodes large T antigen (T-ag) (90–100 kDA nu-
clear protein) and the latter, small T-ag (17–22 kDa) viral cap-
sid proteins VP1, VP2, andVP3 [13]. Large T-ag acts similarly
as many other known oncoproteins of tumor viruses by inter-
fering with tumor suppressor proteins pRb and p53 [8, 11].
Roughly 80–90% of the population are latent carriers of
JCPyV and BKPyV and primary infections are usually mani-
fested subclinically during early childhood [11, 15, 17]. In
healthy individuals, secretion of JCPyV and BKPyV might
occasionally be detected in urine and saliva [18]. In the case
of immunocompromised patients, however, polyomavirus re-
activation may cause severe complications. These include
polyomavirus-associated nephropathy due to BKPyV reactiva-
tion in kidney transplant recipients and JCPyV-related progres-
sive multifocal leukoencephalopathy [15]. HPVs are widely
studied and the causality of HPV type 16 and squamous cell
carcinoma (SCC) has been classified as grade 1 (IARC vol
100, 2009) [19]. The etiological link between HPV and SCC
has specially been shown in cancers of uterine cervix and oro-
pharynx [6, 20]. HPV has also been detected in salivary gland
ACC although the connection between HPV and ACC does
not seem to be strong [21–23]. According to the “hit and run
theory,” different viruses may contribute to tumorigenesis, for
instance, polyomaviruses could augment the oncogenic prop-
erties of HPV during their co-infections [8].
Altogether, studies on HPyVs, HPVs, and salivary gland
tumors are sparse and as far as we know, there are no previous
publications on the presence of polyomaviruses in ACC. The
aim of this study was to assess the prevalence of the three
polyomaviruses, SV40, JCPyV, and BKPyV, and HPV in
ACC samples of minor salivary and mucous glands.
Materials and methods
Patient and tumor characteristics
Table 1 summarizes the demographic data and tumor charac-
teristics in a retrospective series on 68 patients with MiSG
ACC. The patients were diagnosed and treated at the
Department of Otorhinolaryngology – Head and Neck
Surgery, Helsinki University Hospital (Helsinki, Finland) be-
tween 1974 and 2012. The referral area for this tertiary care
center currently is 1.6 M. The clinical data of this series have
been characterized in our previous study [24] and the Ki67
immunostaining results collected from the same hospital data
were now added. The tumor samples were re-evaluated and
validated according to the diagnostic criteria by the classifica-
tion of the World Health Organization classification (both
2005 and 2017) [3, 25]. The present tumor, node, metastasis
(TNM) classification does not include tracheal tumors, and
thus, the TNM classes on six (8.8%) tracheal ACCs are not
given. Additionally, in four cases (5.9%), the TNM class could
not be defined.
Table 1 Characterization of the 68 patients with an adenoid cystic
carcinoma of minor salivary and mucous glands
N %
Sex
Male 29 42.6
Female 39 57.4
Female/male ratio 1.35
Median age, years (range) 58 (24–88)
Tumor site
Oral cavity 41 60.3
Paranasal cavities 6 8.8
Trachea 6 8.8
Nasopharynx 5 7.4
Oropharynx 3 4.4
Ear 4 5.9
Larynx 2 2.9
Esophagus 1 1.5
T class
T1 18 26.5
T2 12 17.6
T3 6 8.8
T4 22 32.4
N/A 4 5.9
N class
N0 54 79.4
N1 1 1.5
N2 3 4.4
N/A 4 5.9
Stage
I 16 23.5
II 12 17.6
III 7 10.3
IV 23 33.8
N/A 4 5.9
N/A, not available
TNM and stage classification for 62 tumors (trachea excluded)
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Altogether, 68 paraffin blocks of tumor samples were avail-
able. Samples included 48 samples from primary tumors and
20 disease failures from 15 patients; altogether, we were able
to study samples from 53 patients. In addition, ten normal
salivary gland tissue samples from the same patients were
used as normal controls.
The study comprised MiSG and mucous excreting gland
samples from the head and neck area including trachea and
esophagus. These gland types in the upper gastrointestinal
tract and in the respiratory tract have similar structure and
function. They maintain the overall moisturizing of the muco-
sa. MaSGs on the other hand are activated mainly during
eating when they produce serous saliva. Due to the location
of MiSGs, just beneath the epithelium, different carcinogenic
agents and oncoviruses might have easier access to MiSGs
compared with MaSGs.
Institutional Research Ethics Board approved the study
concept (Dnro 31/13/03/02/2010, 01 February 2010) and
Statistics Finland provided the dates and causes of death.
DNA extraction
Formalin-fixed and paraffin-embedded biopsy samples
DNAwas extracted from 5-μm-thick deparaffinized sections
(1 cm2 in total area) with the high salt method [26]. In brief,
after deparaffinization, the sections were lysed in lysis buffer
(10 mM Tris-HCl, 400 mM NaCl, and 2 mM EDTA, pH 8.2)
with proteinase K (200 μg/mL) overnight at + 37 °C. After
digestion, proteins were precipitated with saturated NaCl and
the DNAwith ethanol.
HPV detection
DNA was amplified with primer sets 1 and 2 from the
Multiplex HPV Genotyping Kit® (DiaMex GmbH,
Germany). Primer set 1 contains all HPV primers: nine
biotinylated forward and three reverse primers for ampli-
fying the HPV types under investigation. Primer set 2
(DNA quality control primers) contains primers for the
amplification of a ß-globin gene fragment to verify the
amount and the quality of human genomic sample DNA.
A negative control contained no genomic DNA to confirm
the absence of a contamination in the amplification reac-
tions. Multiplex HPV Genotyping Kit® detects the follow-
ing 24 low risk (LR)- and high risk (HR) -HPV genotypes:
LR-HPV6, 11, 42, 43, 44, and 70 and HR-HPV16, 18, 26,
31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, and
82. The labeled hybrids were analyzed with a Luminex
LX-100 analyzer (Bio-Plex 200 System, Bio-Rad
Laboratories, Hercules, USA).
Quantitative detection of SV40, JCPyV, and BKPyV
Presence of SV40, JCPyV and BKPyV DNA in the samples
was detected by quantitative polymerase chain reaction
(qPCR) (Roche, Light Cycler 96) targeting their oncogenic
large T-ag as described byMcNees and coworkers, with slight
modification [15]. RNase P was used as a reference gene
(TaqMan® Copy Number Reference Assay RNase, Applied
Biosystems, Foster City, CA, USA) to a relative expression of
the target genes.
The primers and probes were designed as described earlier
[15] and produced by Life Technologies as given in Table 2.
The probes for the target genes SV40, JCPyV, and BKPyV
were labeled with 6-carboxyfluorescein (FAM) and (VIC) was
used for labeling the probe for the reference gene RNase P.
The qPCR reactions were performed in 20 μl volume in micro
titer plate. The following reaction conditions were used:
900 nM of each primer and 100 nM of their analogous probe,
10 μl of TaqMan® Universal Mix II and 300 ng template
DNA. The detection of the reference gene TaqMan® RNase
P (Applied Biosystems) was performed according to the man-
ufacturer’s recommendations. The conditions for all qPCR
reactions were as follows: 2 min at 50 °C, 10 min denaturation
at 95 °C followed by 45 cycles of amplification with 95 °C
denaturation for 15 s, and annealing/extension at 60 °C for
60 s. Amplification data measured as an increase in reporter
fluorescence were collected in real time and analyzed by the
Roche, Light Cycler 96 software.
The linear standard curves for JCPyV and BKPyV were
obtained with a serial dilution of plasmids with amounts rang-
ing from 1.2*10^2ng/μl to 1.2*10^-2 ng/μl for JCPyV and
9.5*10^0 to 9.5*10^-3 ng/μl for BKPyV. The standards for
SV40 detection were constructed with a serial dilution of
COS1 cell line DNA (which contains one copy of
SV40/cell) with an amount range from 5.0*10^4 to
5.0*10^0cells/μl, while the standards for the reference gene
RNase P were acquired with a serial dilution of human pla-
centa DNA extractions (Sigma-Aldrich, Darmstadt, Germany)
ranging from 5.09*10^2 to 5.09*10^-2. Cq values of less than
37 were considered positive. The copy numbers were calcu-
lated as copies in 1 μg human DNA.
Immunohistochemistry
Immunohistochemistry was performed for JCPyV-positive
samples only as BKPyVand SV40 remained qPCR negative.
For immunohistochemistry, there are 4-μm-thick sections of
formalin-fixed and paraffin-embedded blocks. The slides were
deparaffinized in xylene and rehydrated in a series of ethanol
solutions. Endogenous peroxidase activity was blocked by
incubation of the slides with 3% hydrogen peroxide for
15 min. Epitope retrieval was performed using boiling in
1 mM citrate buffer, pH 6.0 in the microwave for 5 min, twice.
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The primary antibody used was a mouse monoclonal anti-
simian virus T-ag that cross-reacts with JCPyV T-ag (Anti-
SV40 Antibody, clone Pab101, LifeSpan BioSciences Inc.,
Seattle WA, USA) and the dilution of 1:75 was used. The
tissue was incubated with the primary antibody overnight,
followed by detection with Dako REAL Detection System,
Peroxidase/DAB+, Rabbit/Mouse, Dako, Glostrup,
Denmark) and counterstained with hematoxylin.
Results
The presence of JCPyV, BKPyV, SV40, and HPV in ACC
and in normal salivary gland tissue
All 68 samples remained negative for BKPyV, SV40, and
HPV but seven of 68 (10.3%) samples showed JCPyV DNA
positivity. The characterization of the seven patients with
JCPyV-positive ACC is given in Table 3. The viral load of
JCPyV was low in all samples varying from 1 to 226
copies/μg DNA. The locations of JCPyV DNA-positive
ACCs were as follows: two in the trachea, one in the lung
metastasis of a tracheal tumor, one in the paranasal sinuses
(stage IV tumor), two in the oral cavity (stage I and IV tu-
mors), and one in local disease failure of an oral cavity tumor.
All the normal salivary gland control tissues showed negativ-
ity to JCPyV, BKPyV, and SV40.
Patients with JCPyV-positive ACC
Table 3 shows the details of the seven patients with JCPyV
DNA-positive ACC. The mean age of the patients with
JCPyV DNA-positive tumor was 59 years (range, 43–80)
and female to male ratio was 2.5. In the whole cohort, the
mean age was similar, 58 years (range, 24–88), but the female
and male ratio was smaller, being 1.35. Among the JCPyV-
positive ACCs, the most common growth pattern was cribri-
form (42.8%), and the secondwas a combination of cribriform
and tubular (28.6%), followed by tubular (14.3%), and
combination of cribriform and solid (14.3%), which simulates
the pattern of the whole cohort [24]. Neural invasion (perineu-
ral, intraneural, or both) was present in three (42.9%) out of
the JCPyV-positive tumors and in 57.4% in the whole cohort.
Proliferation index of Ki67 immunostaining varied from 4 to
35% (median 30%) among the JCPyV-positive tumors and
from 4 to 80% (median 30%) in the whole cohort.
Immunohistochemistry versus JCPyV DNA positivity
In total, three out of the seven JCPyV DNA-positive tumor
sections showed weak nuclear immunohistochemistry positiv-
ity for large T-ag as presented in Figs. 1 and 2. Copy numbers
for two tracheal tumors and one oral cavity tumor were 1.11,
33.95, and 3.25/1 μg DNA, respectively. Immunopositivity
had no association with the clinical outcome of the disease.
Second primary tumors
Of note is that some of the patients with JCPyVDNA-positive
ACC suffered from other malignancies as well. One patient
with a tracheal ACC with thyroid gland invasion was in addi-
tion diagnosed with a papillary microcarcinoma in the thyroid
gland. The patient with an early stage I ACC in oral cavity
died of SCC of the lungs soon after ACC treatment.
Furthermore, the patient with ACC in paranasal sinuses had
recovered from lymphoma 6 years earlier.
Discussion
Our present results show that JCPyV may be found in MiSG
ACC samples by qPCR. However, the prevalence of JCPyVin
ACC was low, i.e., only 10.3%, and JCPyV presented with
low copy numbers. Three out of the seven JCPyV-positive
tumors were from the oral cavity while the rest were located
in the upper and lower airways. As the number of JCPyV-
positive cases was sparse and the viral loads were low, we
can only speculate the possible viral role as an etiological
Table 2 Primers and probes for
SV40, JCPyV, and BKPyV Name Sequence detection
SV40 primer forward GAT GGC ATT TCT TCT GAG CAA A
SV40 primer reverse GAATGG GAG CAG TGG TGG AA
JCPyV primer forward TTC TTC ATG GCA AAA CAG GTC TT
JCPyV primer reverse GAATGG GAATCC TGG TGG AA
BKPyV primer forward CTT TCT TTT TTT TTT GGG TGG TGT T
BKPyV primer reverse TTG CCA GTG ATG AAG AAG CAA
SV40 T-ag probe 5′-FAM CAG GTT TTC CTC ATTAAA
JCPyV T-ag probe 6 FAM CCA CTT CTC ATTAAATG
BKPyV T-ag probe 6 FAM AGT GTT GAG AAT CTG C
Adapted from McNees et al. 2005
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factor for ACC. A “hit and run hypothesis” has been proposed
for certain oncoviruses. Accordingly, this hypothesis claims
that viruses can mediate cellular transformation through an
initial “hit,” while maintenance of the transformed state is
compatible with the loss (“run”) of viral molecules [27]. The
low copy numbers in our study suggest the role of JCPyV in
hit and run carcinogenesis model rather than as a continuous
driver of the tumor formation. None of the HPyVs were de-
tected in the normal salivary gland control tissue.
We were able to locate large T-ag on nuclei of the tumor
cells by using SV40 antibody, which is cross-reacting with
both JCPyVand BKPyV. qPCR technique is an accurate meth-
od for detecting HPyV DNA, but in the current study, immu-
nohistochemical expression did not correlate well with qPCR
findings, while only three out of the seven JCPyV-positive
samples stained positively. Possible explanation for the nega-
tive staining might be that only few cells in the samples in-
fected with JCPyV are transcriptionally and translationally
active. According to the “hit and run theory,” positive signals
are detected only from sporadic cells (Figs. 1 and 2). Another
possibility is that these approximately 7 μm wide cells might
have been cut out from the deeper sections prepared for
immunohistochemistry.
The etiological risk factors for all salivary gland malignan-
cies include exposure to nickel compounds and silica dust,
employment at rubber manufacturing, hairdressers´, and beau-
ty shops, as well as irradiation, EBV, and HIV infection [10,
28, 29]. At molecular level, germline BRCA mutations and
genetic variants in DNA double-strand brake repair genes
have been related to the risk for salivary gland cancers includ-
ing ACC [3].
As far as we know, there are no previous studies on the
prevalence of JCPyV or other HPyVs in ACC. As discussed
earlier, 80–90% of population are latent carriers of JCPyVand
BKPyV and HPyVs have been detected in saliva of healthy
individuals, which strengthens the hypothesis of saliva being
the transmission route for HPyVs [11, 15, 17, 18]. Thus, the
reservoir of HPyVs might be in salivary glands or in oral or
oropharyngeal mucosa. An earlier experimental study showed
that the injection of polyomavirus into salivary gland tissue of
mice resulted in tumor formation resembling that of human
pleomorphic adenoma [30]. Further, SV40 DNA has been
identified in pleomorphic adenoma of parotid gland [31].
Overall, studies concerning HPyVs in head and neck can-
cers are rare [7, 9, 11, 32, 33]. Kutsuna et al. have linked high
viral JCPyV load to oral SCC of the tongue, but they did not
find any prognostic value for JCPyV [11]. Zheng et al. sug-
gested that JCPyV could have an oncogenic role in the squa-
mous cell carcinogenesis of tongue, pharynx, and larynx [32].
Contradictory to their findings, Polz-Gruszka et al. did not
find JCPyV in any of the 62 oropharyngeal SCC in their series
but found BKPyV in 17.7% of the tumor samples [7]. In these
studies, viral DNA was detected by qPCR [7, 11, 32]. Some
studies have reported negative HPyV results in head and neck
cancer. Palmieri et al. did not detect SV40, BKPyV, or JCPyV
DNA by qPCR evaluation in oral cavity SCC [9].
HPVs have been studied in ACC but the association does
not seem to be strong [21–23]. However, recently, a new sub-
type of non-keratinizing SCC has been found in the sinonasal
area having features of both ACC and SCC and being usually
HPV type 33 positive [3, 34]. This entity is named as HPV-
related multiphenotypic sinonasal carcinoma [3, 34]. In our
study, HPV-positive ACCs were not detected.
Further studies are thus needed to understand the possible
role of HPyV in the carcinogenesis of ACC.
Conclusions
Only JCPyV DNA but not SV40, BKPyV, or HPV was found
in ACC from the upper and lower airways. JCPyV copy
Fig. 1 Immunohistochemical staining for large T antigen showing
JCPyV positivity in adenoid cystic carcinoma of the trachea (patient #1
in Table 3)
Fig. 2 Immunohistochemical staining positivity for large T antigen in
adenoid cystic carcinoma of the trachea (patient #2 in Table 3)
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numbers were low which might support its role as a “hit and
run agent” in ACC carcinogenesis.
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